Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Change in Acquisitions & Divestments: 2011-2024

Historic Change in Acquisitions & Divestments for Agios Pharmaceuticals (AGIO) over the last 14 years, with Dec 2024 value amounting to $818.4 million.

  • Agios Pharmaceuticals' Change in Acquisitions & Divestments rose 72.67% to $272.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $931.1 million, marking a year-over-year increase of 8.97%. This contributed to the annual value of $818.4 million for FY2024, which is 21.30% up from last year.
  • Agios Pharmaceuticals' Change in Acquisitions & Divestments amounted to $818.4 million in FY2024, which was up 21.30% from $674.7 million recorded in FY2023.
  • Agios Pharmaceuticals' 5-year Change in Acquisitions & Divestments high stood at $1.1 billion for FY2022, and its period low was $647.7 million during FY2020.
  • In the last 3 years, Agios Pharmaceuticals' Change in Acquisitions & Divestments had a median value of $818.4 million in 2024 and averaged $879.7 million.
  • Per our database at Business Quant, Agios Pharmaceuticals' Change in Acquisitions & Divestments surged by 38.13% in 2022 and then tumbled by 41.14% in 2023.
  • Yearly analysis of 5 years shows Agios Pharmaceuticals' Change in Acquisitions & Divestments stood at $647.7 million in 2020, then grew by 28.12% to $829.8 million in 2021, then surged by 38.13% to $1.1 billion in 2022, then tumbled by 41.14% to $674.7 million in 2023, then climbed by 21.30% to $818.4 million in 2024.